Multimarket contact in pharmaceutical markets
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Coronado Saleh, Francisco Javierca
- dc.contributor.author Jiménez-Martín, Sergica
- dc.contributor.author Marín, Pedro L.ca
- dc.contributor.other Universitat Pompeu Fabra. Departament d'Economia i Empresa
- dc.date.accessioned 2017-07-26T10:50:30Z
- dc.date.available 2017-07-26T10:50:30Z
- dc.date.issued 2007-04-01
- dc.date.modified 2017-07-23T02:43:16Z
- dc.description.abstract We analyze the effect of multimarket contact on the pricing behavior of pharmaceutical firms controlling for different levels of regulatory constraints using the IMS MIDAS database for the industry. Theoretically, under product differentiation, firms may find it profitable to allocate their market power among markets where they are operating, specifically from more collusive to more competitive ones. We present evidence for nine OECD countries suggesting the existence of a multimarket effect for more market friendly countries (U.S. and Canada) and less regulated ones (U.K., Germany, Netherlands), while the results are more unstable for highly regulated countries with some countries being consistent with the theory (France) while others contradicting it (Japan, Italy and Spain). A key result indicates that in the latter countries, price constraints are so intense, that there is little room for allocating market power. Thus equilibrium prices are expected in general to be lower in regulated countries.
- dc.format.mimetype application/pdfca
- dc.identifier https://econ-papers.upf.edu/ca/paper.php?id=1033
- dc.identifier.uri http://hdl.handle.net/10230/1209
- dc.language.iso eng
- dc.relation.ispartofseries Economics and Business Working Papers Series; 1033
- dc.rights L'accés als continguts d'aquest document queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/es/
- dc.subject.keyword pharmaceutical prices
- dc.subject.keyword multimarket contact
- dc.subject.keyword regulation
- dc.subject.keyword Microeconomics
- dc.subject.keyword Labour, Public, Development and Health Economics
- dc.subject.keyword Statistics, Econometrics and Quantitative Methods
- dc.title Multimarket contact in pharmaceutical marketsca
- dc.type info:eu-repo/semantics/workingPaper